## Abstract DOI 10.1002/cncr.11440
Hepatic steatosis and the risk of hepatocellular carcinoma in chronic hepatitis C
โ Scribed by DINESH KUMAR; GEOFFREY C FARRELL; JAMES KENCH; JACOB GEORGE
- Book ID
- 108950455
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 99 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0815-9319
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## BACKGROUND Hepatic steatosis is one of the histopathologic features of chronic hepatitis C. It was reported recently that the expression of hepatitis C virus (HCV) core protein in transgenic mice induced hepatocellular carcinoma (HCC) in association with steatosis. The objective of
Hepatic steatosis has been reported as one of the characteristics which discriminates hepatitis C from other forms of hepatitis, besides lymphoid follicles and bile duct damage. However, it is unclear whether or not the presence of hepatitis C virus (HCV) itself is associated with the development of
Hepatic steatosis is common in chronic hepatitis C and has been linked to concurrent obesity, insulin resistance, diabetes, disease severity, and poor response to therapy. Racial differences in rates of obesity and diabetes may contribute to racial differences in hepatic steatosis and treatment resp
We read with great interest the articles by Lai et al. 1 and Veldt et al. 2 , which show an association between diabetes mellitus and hepatocellular carcinoma (HCC) for patients with chronic hepatitis C. Both of their results indicate that diabetes mellitus is not significantly associated with the d